Neurochemistry International
Издатель: Elsevier · ISSN 0197-0186 · 45 статей
- Neuroinflammation and vascular pathology in Alzheimer's Disease: The NRF2/HO-1 axis as a modulator of microglial phenotypes
- mGluR5-PKCγ signaling disrupts the AMPA receptor subunit homeostasis and drives central sensitization in chronic migraine
- Implementation rules and research status of acupuncture therapy for anxiety disorders
- Restoration of StAR-governed neurosteroids with all-trans retinoic acid in alleviating cognitive deficits in a humanized amyloid-β knock-in mouse model of late-onset Alzheimer's disease: New insights into therapeutics
- An in vitro platform for rapid screening of DRG-derived pro-migratory signals in microglia
- Anterior cingulate cortex glutamatergic projection neurons modulate motion sickness susceptibility via a cortico-vestibular circuit
- NOD1 contributes to reduced postoperative memory performance induced by preoperative sleep deprivation and anesthesia/surgery in mice
- Glyceryl tribenzoate, a flavoring agent, stimulates hippocampal plasticity and protects memory via PPARα
- Targeting oxidative stress and neuroinflammation: Analgesic effects of 4-(phenylsulfanyl)butan-2-one on chronic constriction injury-induced peripheral neuropathic pain in rats
- Fucosylated chondroitin sulfate modulates microglia-associated responses and reduces Aβ burden with ERK1/2-related signaling changes
- Hippocampal HMGB1/TLR4 activation elevates KYNA levels and contributes to novel-object recognition dysfunction in LPS-treated mice
- Inhibition of Ptbp1 in microglia alleviates neuroinflammation by the Cbx5-Ifitm3 axis
- Pathway-selective Gi1, but not Gq, protein activation distinguishes hallucinogenic from non-hallucinogenic serotonin 5-HT2A receptor agonists in the human cortex
- KBN2201 attenuates the hippocampal astrocytic NOX4-MPO/OPN axis and restores mitochondrial protein markers not recovered by chronic L-DOPA in an MPTP mouse model of Parkinson's disease
- Optimizing cognitive and behavioural recovery after stroke: clinical integration of dietary supplements with a focus on ω-3 fatty acids